跳至主要内容
临床试验/DRKS00006176
DRKS00006176进行中(未招募)未知

Prospective, randomized clinical trial for the comparison of the voice protheses Phonax® and Provox II® - Phonax

Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde Leipzig0 个研究点目标入组 22 人开始时间: 2014年5月21日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • histologically verified, primary resectable Larynx/Hypopharynxcarcinoma
  • indikation for laryngectomy with primary creation of a tracheo esophageal fistula
  • planned curative resection (R0-resection)
  • stage II/IV A ollowing UICC (without T1)
  • low to slightly enhanced risk of anesthesia
  • adequate bone marrow-, liver- and kindneyfunction
  • Karnofsky-Index =70%
  • Age 18-80 Years
  • written informed consent

排除标准

  • tumorspezifc pre-treatment (chemotherapy, radiation therapy)
  • Metachrone or synchrone malignom (exception: basaliom or low-risk prostatecarcinoma) [In case of a controlled tumor at a different location with a treatment free intervall of more than 5 years, inclusion might be possible after consultation of the co-ordinating investigator]
  • life expectancy < 6 months
  • acute infection or fever
  • anamnestic HIV-infection or othe immune suppression
  • serious cardio-pulmonary concomittant disease (heart insufficiency grade III and IV following NYHA scale, myocardial infarction, angina pectoris, respiratoric insufficiency serious Asthma bronchiale, COPD (FEV1 <35%))
  • chronic disease with permanent therapy (uncontrolled Diabetes, rheumatoide Arthritis) particularly steroid therapy
  • other concomittant diseases, which exclude the patient from the trial from the perspective of the trial physician
  • analphabetism
  • intolerance regarding the materials of the voice protheses
  • experienced low patient's compliance
  • regular follow-up impossible (e. g. patient lives outside of Germany)
  • lack of or patial legal capcity of the patient
  • participation in another clinical trial or application of a not yet registered substancewithin 30 days before trial start
  • pregnant or nursing
  • fertile female patients (< 2 years after the last spontaneous menstruation) without effective contraception (implants, injections, oral contraceptives, intrauterine devices, vasectomized partner)

研究者

发起方
Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde Leipzig

相似试验